Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1

[1]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019. , 2022, Neuro-oncology.

[2]  P. Bartenstein,et al.  Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET , 2022, EJNMMI Radiopharmacy and Chemistry.

[3]  D. Georg,et al.  Impact of SSTR PET on Inter-Observer Variability of Target Delineation of Meningioma and the Possibility of Using Threshold-Based Segmentations in Radiation Oncology , 2022, Cancers.

[4]  O. Schillaci,et al.  Somatostatin Receptor Targeted PET-Imaging for Diagnosis, Radiotherapy Planning and Theranostics of Meningiomas: A Systematic Review of the Literature , 2022, Diagnostics.

[5]  P. Wen,et al.  Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group. , 2022, Neuro-oncology.

[6]  H. Shu,et al.  Low-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG 0539. , 2022, Neuro-oncology.

[7]  M. G. Sabini,et al.  The Role of [68Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials , 2022, Cancers.

[8]  T. Schwartz,et al.  The Simpson Grading: Is It Still Valid? , 2022, Cancers.

[9]  J. Palmer,et al.  68Ga-DOTATATE PET-based Radiation Contouring Creates More Precise Radiation Volumes for Meningioma Patients. , 2022, International journal of radiation oncology, biology, physics.

[10]  R. Appay,et al.  [The 2021 WHO classification of tumours of the central nervous system]. , 2021, Annales de pathologie.

[11]  T. Santarius,et al.  Proposal of a new grading system for meningioma resection: the Copenhagen Protocol , 2021, Acta Neurochirurgica.

[12]  David C. Jones,et al.  Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  N. Albert,et al.  Multimodal therapy of cavernous sinus meningioma: Impact of surgery and 68Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome , 2021, Neuro-oncology advances.

[14]  Wengen Chen,et al.  68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas , 2021, Radiation Oncology.

[15]  K. Jurkschat,et al.  Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals , 2021, Pharmaceuticals.

[16]  G. Reifenberger,et al.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.

[17]  M. Weller,et al.  EANO guideline on the diagnosis and management of meningiomas. , 2021, Neuro-oncology.

[18]  K. Jurkschat,et al.  PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE. , 2021, Clinical nuclear medicine.

[19]  I. Law,et al.  Improved Detection of Postoperative Residual Meningioma with [68Ga]Ga-DOTA-TOC PET Imaging Using a High-resolution Research Tomograph PET Scanner , 2021, Clinical Cancer Research.

[20]  Kaith K. Almefty,et al.  Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience. , 2020, Journal of neurosurgery.

[21]  P. Zhao,et al.  Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma , 2020, Frontiers in Oncology.

[22]  N. Albert,et al.  Simpson Grade Revisited - Intraoperative Estimation of the Extent of Resection in Meningiomas Versus Postoperative Somatostatin Receptor Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging. , 2020, Neurosurgery.

[23]  J. Lemée,et al.  Histological transformation in recurrent WHO grade I meningiomas , 2020, Scientific Reports.

[24]  G. Fink,et al.  Flare Phenomenon in O-(2-18F-Fluoroethyl)-l-Tyrosine PET After Resection of Gliomas , 2020, The Journal of Nuclear Medicine.

[25]  K. Jurkschat,et al.  Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  Raymond Y Huang,et al.  DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. , 2019, Neuro-oncology.

[27]  Raymond Y Huang,et al.  Imaging and diagnostic advances for intracranial meningiomas. , 2019, Neuro-oncology.

[28]  K. Aldape,et al.  Advances in multidisciplinary therapy for meningiomas. , 2019, Neuro-oncology.

[29]  Raymond Y Huang,et al.  Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group. , 2018, Neuro-oncology.

[30]  P. Brastianos,et al.  Advances in meningioma genetics: novel therapeutic opportunities , 2018, Nature Reviews Neurology.

[31]  Martin Sill,et al.  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. , 2017, The Lancet. Oncology.

[32]  M. Reiser,et al.  Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI , 2017, The Journal of Nuclear Medicine.

[33]  A. Órfão,et al.  Re-Evaluating Simpson Grade I, II, and III Resections in Neurosurgical Treatment of World Health Organization Grade I Meningiomas. , 2016, World neurosurgery.

[34]  Y. Shoshan,et al.  Review of controversies in management of non-benign meningioma , 2016, Journal of Clinical Neuroscience.

[35]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[36]  J. Schramm,et al.  The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. , 2016, Journal of neurosurgery.

[37]  U. Schüller,et al.  Increased 68Ga-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free Tissue , 2015, The Journal of Nuclear Medicine.

[38]  A. Haug,et al.  Ga-68-DOTA-TATE PET/CT for Discrimination of Tumors of the Optic Pathway , 2015, Orbit.

[39]  J. Fandino,et al.  The role of intraoperative magnetic resonance imaging in complex meningioma surgery. , 2013, Magnetic resonance imaging.

[40]  U. Haberkorn,et al.  Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  S. Lönn,et al.  Long-term 25-year follow-up of surgically treated parasagittal meningiomas. , 2011, World neurosurgery.

[42]  M. Maor,et al.  Radiotherapy after surgery for benign cerebral meningioma. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  A. Nanda,et al.  Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. , 2017, Journal of neurosurgery.

[44]  D. Simpson.  THE RECURRENCE OF INTRACRANLAL MENINGIOMAS AFTER SURGICAL TREATMENT , 2022 .